ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMAGlobeNewsWire • 11/28/24
Shareholders that lost money on Humacyte, Inc.(HUMA) Urged to Join Class Action – Contact Levi & Korsinsky to Learn MoreAccesswire • 11/27/24
Kirby McInerney LLP Reminds Humacyte, Inc. (HUMA) Investors of Class Action Filing and Encourages Investors to Contact the FirmGlobeNewsWire • 11/26/24
Humacyte, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before January 17, 2025 to Discuss Your Rights - HUMAAccesswire • 11/26/24
The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 – HUMAGlobeNewsWire • 11/26/24
The Schall Law Firm Urges Stockholders With Losses In Humacyte Inc To Join A Securities Fraud CaseAccesswire • 11/26/24
HUMA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Humacyte, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 11/26/24
Humacyte (HUMA) Faces Class Action Lawsuit After FDA Inspection Reveals Manufacturing Issues – Hagens BermanGlobeNewsWire • 11/25/24
Humacyte, Inc. Is Being Sued For Violating Securities Laws And Affected Investors Can Assist The Schall Law FirmAccesswire • 11/25/24
Investors who Lost Money on Humacyte, Inc. (HUMA) Should Contact Levi & Korsinsky About Pending Class Action - HUMAAccesswire • 11/25/24
Humacyte, Inc. Shareholder Alert: Robbins LLP Reminds Investors of the HUMA Securities Class ActionGlobeNewsWire • 11/24/24
Humacyte, Inc. Is Being Sued For Violating Securities Regulations And Affected Investors Are Invited To Contact The Schall Law FirmAccesswire • 11/23/24
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Humacyte, Inc. (HUMA)Business Wire • 11/22/24
Levi & Korsinsky Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 – HUMAAccesswire • 11/22/24
Faruqi & Faruqi Reminds Humacyte Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 – HUMAGlobeNewsWire • 11/22/24
Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)GlobeNewsWire • 11/22/24
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) ShareholdersPRNewsWire • 11/22/24
ROSEN, LEADING INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HUMAGlobeNewsWire • 11/21/24
HUMACYTE, INC. (NASDAQ: HUMA) INVESTOR ALERT: Investors With Large Losses in Humacyte, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsGlobeNewsWire • 11/21/24
HUMA INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In HUMA To Contact Him Directly To Discuss Their OptionsPRNewsWire • 11/21/24
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Humacyte, Inc. (HUMA)GlobeNewsWire • 11/20/24
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) InvestorsBusiness Wire • 11/20/24
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Humacyte, Inc.PRNewsWire • 11/20/24
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) InvestorsBusiness Wire • 11/19/24
Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their RightsBusiness Wire • 11/19/24
